To determine whether the incidence and clinical features of pediatric multiple sclerosis (MS) and other forms of pediatric acquired demyelinating syndromes (ADS) vary by race/ethnicity in a population-based cohort.
Multiple sclerosis (MS) is an acquired, chronic inflammatory demyelinating disease of the CNS that is thought to be triggered by environmental factors in genetically susceptible individuals. MS and its potential precursors, optic neuritis (ON), transverse myelitis (TM), clinically isolated syndrome (CIS), and possibly acute disseminated encephalomyelitis (ADEM), collectively known as acquired demyelinating syndrome (ADS), are increasingly recognized in children. Whether this represents increased clinical awareness or increased exposure to environmental triggers during childhood is unclear. Several pediatric MS and ADS cohorts have been established [1] [2] [3] to study this.
The North American pediatric ADS cohorts described broader racial/ethnic diversity than the traditional predominantly Caucasian, adult MS populations. The Northern California cohort 2 reported a high proportion of Hispanic children (48%) and the Canadian cohort 1, 4 reported a high proportion of children of Caribbean, Asian, and Middle Eastern descent. It is unknown whether this increase in racial/ ethnic diversity indicates that environmental MS risk factors are becoming more prevalent during childhood among certain minorities or simply reflects a shift in the ethnic distribution of general populations from which these cohorts were obtained.
There is only one previous report of the incidence of pediatric ADS 1 with an overall rate of 0.9 per 100,000 Canadian children. The majority of children in this study were white and pediatric MS and incidence rates stratified by race/ethnicity were not reported. 1 The purpose of this study was to establish estimates of the incidence of pediatric MS and other forms of ADS in a multiethnic population-based cohort of children.
METHODS Standard protocol approvals, registrations, and patient consents. The institutional review board
at Kaiser Permanente Southern California (KPSC) approved this study. Informed consent was waived as this was a database and chart review study only without direct patient contact.
Case identification. KPSC is a large prepaid health maintenance organization with over 3.2 million members including over 900,000 members 18 years and younger. It provides comprehensive health care coverage to ϳ20% of the population in the geographic area it serves. The cost of specialist consultations, hospitalizations, MRI scans, other diagnostic tests, and medications is fully covered. The KPSC pediatric membership is representative of the general pediatric population in Southern California with respect to ethnicity, age, gender, and socioeconomic status with the exception of an underrepresentation of the lowest and highest ends of the socioeconomic spectrum. 5 To identify potentially incident cases, we searched electronic databases for any mention of ICD-9 diagnostic codes for MS and other ADS (see table e-1 on the Neurology ® Web site at www.neurology.org for list of codes) in subjects Յ18 years of age, January 1-December 31 of 2004, 2005, 2006, 2007, 2008, and 2009 , including all inpatient and outpatient encounters since enrollment into the health plan (n ϭ 205). Diagnoses were confirmed and additional clinical details were extracted through full medical records abstraction including all inpatient and outpatient records, MRI scans, and diagnostic test results by an MS specialist (A.L.G.) according to the consensus definitions for pediatric ADEM, CIS, neuromyelitis optica (NMO), and MS. 6 Briefly, ADEM required the presence of encephalopathy in addition to multifocal neurologic deficits. A first CNS demyelinating event without encephalopathy (referable to lesions outside of the optic nerves or spinal cord) was classified as CIS and further subdivided into monofocal or multifocal CIS (deficits referable to a single or multiple CNS lesions, respectively). Pediatric MS was defined as 2 or more episodes of CNS demyelination separated in time and space or a single such episode followed by new gadolinium-enhancing or T2 lesions on MRI scan at least 3 months after the initial event. The presence of ON and TM and either a spinal MRI lesion extending over 3 or more segments or a NMO-positive antibody was classified as NMO. Complicated cases (n ϭ 11) were adjudicated by a second MS specialist (E.W.) and classified by consensus. All children with optic neuritis had been evaluated by ophthalmologists who confirmed the diagnosis. Idiopathic transverse myelitis was defined according to proposed consensus definitions 7 after exclusion of infectious, vascular, and other inflammatory causes of myelopathy. 8
Race and ethnicity. Race and ethnicity information were obtained from medical records review (cases only), health plan administrative records, and birth certificates (all children). 9 We categorized race and ethnicity as non-Hispanic white, Hispanic white, black (regardless of ethnicity), Asian or Pacific Islander, other or multiple race/ethnicity, and unknown due to missing information. For unknown race and ethnicity information (0% of cases, 45.9% of cohort members), a previously validated imputation algorithm 5 was used based on birth certificate data (3%), language preference (2.7%), surname (20.9%), and address information geocoded to the US Census Block (11.9%). 9 -12 Those children who remained unknown due to insufficient probability for imputation (7.4%) were assumed to have the same race/ethnicity distribution as the known population. The racial and ethnic distribution of the population remained essentially unaltered after race imputation.
Statistical analyses.
Person-years of observation by race/ ethnicity were calculated by adding the number of members in each racial/ethnical group at the beginning of the third quarter of each incident year (2004 -2009). Confidence intervals for incidence rates assumed that the number of events follow a Poisson distribution. Risk ratios comparing incidence rates between racial/ethnic groups were calculated using 2 with Fisher exact test with white non-Hispanic as the reference category. Age was dichotomized based on average age at puberty (0 -12, 13-18 years) and gender-adjusted standardized incidence rates were calculated according to the 2000 US Census population. The means and standard deviations of normally distributed variables were compared using 2-sample t tests and for binary or categorical variables, 2 with Fisher exact test. All analyses were conducted using SAS software v9.1 (Cary, NC). The clinical phenotype varied by age with children 12 years and under being more likely to present with ADEM than older children and a lack of a female predominance among younger children ( figure 1) .
RESULTS
The incidence of pediatric ADS including MS and other forms of ADS was higher in black and Asian com-pared with white Hispanic and white non-Hispanic children ( figure 2) . With white non-Hispanic children as the reference group, the risk of ADS was 4.25 (95% confidence interval [CI] 1.97-9.23; p Ͻ 0.001) higher in blacks; 2.72 (95% CI 1.09 -6.48; p ϭ 0.02) in Asians; and 1.45 (95% CI 0.78 -2.83; p ϭ 0.26) in Hispanic children. The age and gender-adjusted standardized incidence rate and estimated number of US children who are diagnosed with ADS, MS, and other forms of ADS are presented in table 2.
Of the 58 children with incident ON, TM, or other forms of CIS identified during the study period, 20 (34.5%) developed a chronic form of pediatric ADS during the study period after an average follow-up time of 3.25 years (table 1). Nineteen were subsequently diagnosed with MS and one child who presented with TM developed ON within 6 months and was diagnosed with antibody-positive NMO.
In addition to the 19 incident cases of MS and 1 case of NMO described above, we identified 6 more cases of incident MS and 2 more with incident NMO who were diagnosed at initial clinical presentation for a total of 25 incident cases of MS and 3 incident cases of NMO during the study period. Among the 6 additional incident MS cases, 1 patient had been diagnosed with CIS prior to KPSC membership and 5 patients had the initial onset of symptoms while they were KPSC members during the study period; however, their diagnosis of CIS was
Figure 1 Clinical phenotypes of acquired pediatric CNS demyelinating diseases vary with age
This diagram shows the relative distribution of clinical phenotypes in children with acquired demyelinating syndrome 12 years or younger compared with teenagers, 13 to 18 years of age. Acute disseminated encephalomyelitis (ADEM) (in gold) was rare among teenagers (n ϭ 1) and multiple sclerosis (MS) (blue) was more common than in younger children. A female preponderance was present among teenagers but not younger children. CIS ϭ clinically isolated syndrome; NMO ϭ neuromyelitis optica; ON ϭ optic neuritis; TM ϭ transverse myelitis. missed for the following reasons. In 3 cases the primary care physician and in 1 case the neurologist misdiagnosed the first attack as non-CNS demyelinating diseases and in 1 case the patient did not follow through with neurologic evaluation recommended at the time of initial clinical presentation until after the onset of the second relapse 1.5 years later. The 4 patients who were initially misdiagnosed all developed their second relapse and subsequent diagnosis of MS within 3 to 8 months of their first event. All 5 patients had initial symptoms of monofocal CIS; none presented with ON, TM, or multifocal CIS. DISCUSSION We found that the incidence of pediatric MS and ADS was very low. In our cohort, black children were unexpectedly found to be at least twice as likely to develop pediatric ADS compared with white children. The incidence of pediatric ADS including pediatric MS was also higher in Asians compared with whites. In contrast, Hispanic children had a similar risk and incidence rate of pediatric ADS and MS compared with whites. While most of the children with ADS were Hispanic, this reflects the Hispanic predominance of our general pediatric cohort. Based on our findings, we estimate that the ageand sex-adjusted US census standardized incidence rates for pediatric MS are 0.5 per 100,000 personyears or approximately 380 newly diagnosed cases per year in the United States and 1.63 per 100,000 person-years or approximately 1,250 newly diagnosed children with any acquired demyelinating syndrome per year.
We found a somewhat higher incidence of pediatric ADS than the 0.9 per 100,000 incidence rate previously reported in Canadian children. 1 This modest discrepancy may be because we obtained more complete case capture than the Canadian study, which relied on questionnaires with response rates ranging from 78% to 82% 1 or due to the increased racial and ethnic diversity of our population.
The increase of MS and ADS in black children is a novel finding and suggests that the prevalence of environmental or genetic risk factors may be more common in black compared with white or Hispanic children. It is tempting to speculate that this finding may be explained by the increased prevalence of vitamin D deficiency in dark-skinned individuals. 13 However, our findings do not clearly follow the skin tone gradient associated with low vitamin D. Thus, it is unlikely that low vitamin D alone could explain why the risk of MS and ADS in Hispanic children is the same as in whites. Future studies should explore other environmental risk factors in addition to vitamin D.
As for candidate genetic factors that could explain our findings, HLA-DRB1*15 has been consistently as- sociated with an increased risk of MS 14 -16 but the prevalence of HLA-DRB1 MS risk allele is lower in blacks than whites 16 and unknown in Hispanics. The possibility remains that either non-HLA MS risk alleles may be more common in black compared with white and Hispanic children or that there is a synergistic interaction between low vitamin D and HLA-DRB1*15 17 that is more common in blacks than Hispanics. Future studies of pediatric ADS should include non-MHC risk alleles and stratify analyses by race/ethnicity. It is unclear whether our findings indicate that environmental or genetic risk factors are different in children compared with adults. There are no published studies comparing incidence rates or prevalence ratios from population-based multiethnic cohorts in either children or adults with MS or other forms of ADS. Blacks are believed to have a lower risk of adult-onset MS than whites but evidence for this comes predominantly from ecological studies and a prevalence study of US veterans published in 1979. 18 Future studies of the incidence of MS in population-based multiethnic cohorts are needed to sort this out.
Consistent with the first pediatric ADS incidence study, 1 we found that pediatric ADS is rare. In fact, the primary limitation of our study is the few incident cases particularly of pediatric MS despite the relatively long observation period. Another limitation of our study is the amount of missing selfreported race/ethnicity information. While we used a validated algorithm based primarily on birth certificates, language preference, and surnames, 5 our results should be confirmed in future studies with more complete self-reported race/ethnicity information.
Similar to other studies, we found that ADEM is more likely to be a monophasic illness, occurring in young children, 1, 19, 20 and that the female preponderance typically seen in adult MS was not present in younger children. In our cohort, none of the children with ADEM developed MS despite similar duration of follow-up with children who presented with ON, TM, and other types of CIS, of whom 34.5% converted to MS. It should be noted that this is one of the first studies reporting the conversion to MS after CIS using the 2007 International Pediatric MS Study Group definitions for ADEM. In the past, ADEM and multifocal CIS were often combined under a first demyelinating attack, which may explain why some authors reported higher conversion rates from ADEM to MS. 21, 22 Thus, our findings suggest that children with ADEM should be examined separately from CIS or MS cases in studies of pediatric MS susceptibility or prognosis as ADEM is often not a precursor to MS.
We found that black children have a higher risk of developing MS and other forms of ADS than white or Hispanic children. This finding is novel and high-lights that inclusion of minorities in future studies of pediatric and adult MS incidence, susceptibility, and prognosis may reveal important insights into the etiology of MS and other forms of ADS.
